Treatment initiation rates following fragility fractures have often been reported to be low and in recent years numerous programs have been implemented worldwide to increase them. This study aimed at describing osteoporosis (OP) treatment initiation in a representative sample of women who were hospitalized for a distal forearm fracture (DFF) or proximal humerus fracture (PHF) in 2009–2011 in France. The data source was a nationwide sample of 600,000 individuals, extracted from the French National Insurance Healthcare System database. All women aged 50 years and older who were hospitalized for a DFF or PHF between 2009 and 2011 and who had not received any OP treatment in the preceding 12 months were included in a retrospective cohort study....
Objective The aim of this study was to quantify the global burden of osteoporotic fracture worldwide...
Summary The study explores osteoporosis medication pre-scribing across Canadian provinces and any im...
Objective: To assess patterns of anti-osteoporosis medication (AOM) use over 3 years among women at ...
Osteoporosis and subsequent fractures is a rapidly growing major health problem in many parts of the...
BACKGROUND: Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk o...
SUMMARY: In this observational study of women with an inadequate clinical outcome to osteoporosis th...
UNLABELLED: In this observational study of women with an inadequate clinical outcome to osteoporosis...
Summary: European observational 1-year study assessed osteoporosis and fracture patterns in 3,402 po...
Summary Diagnosis and treatment of osteoporosis in hospitals is poor. We compared patient outcomes b...
Background: A care gap exists between recommendations and practice regarding the diagnosis and treat...
Osteoporosis is a disease characterized by impaired bone microarchitecture and reduced bone mineral ...
Summary: Studies examining real-world effectiveness of osteoporosis therapies are beset by limitatio...
CONTEXT: Evidence is limited on the effects of different patterns of use of postmenopausal hormone t...
Summary Half of Métis citizens, compared to less than 10 % of the general population of Ontario, res...
Context: Evidence is limited on the effects of different patterns of use of postmenopausal hormone t...
Objective The aim of this study was to quantify the global burden of osteoporotic fracture worldwide...
Summary The study explores osteoporosis medication pre-scribing across Canadian provinces and any im...
Objective: To assess patterns of anti-osteoporosis medication (AOM) use over 3 years among women at ...
Osteoporosis and subsequent fractures is a rapidly growing major health problem in many parts of the...
BACKGROUND: Osteoporosis is a major cause of morbidity. Treatment of osteoporosis reduces the risk o...
SUMMARY: In this observational study of women with an inadequate clinical outcome to osteoporosis th...
UNLABELLED: In this observational study of women with an inadequate clinical outcome to osteoporosis...
Summary: European observational 1-year study assessed osteoporosis and fracture patterns in 3,402 po...
Summary Diagnosis and treatment of osteoporosis in hospitals is poor. We compared patient outcomes b...
Background: A care gap exists between recommendations and practice regarding the diagnosis and treat...
Osteoporosis is a disease characterized by impaired bone microarchitecture and reduced bone mineral ...
Summary: Studies examining real-world effectiveness of osteoporosis therapies are beset by limitatio...
CONTEXT: Evidence is limited on the effects of different patterns of use of postmenopausal hormone t...
Summary Half of Métis citizens, compared to less than 10 % of the general population of Ontario, res...
Context: Evidence is limited on the effects of different patterns of use of postmenopausal hormone t...
Objective The aim of this study was to quantify the global burden of osteoporotic fracture worldwide...
Summary The study explores osteoporosis medication pre-scribing across Canadian provinces and any im...
Objective: To assess patterns of anti-osteoporosis medication (AOM) use over 3 years among women at ...